Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-26 @ 5:25 PM
Study NCT ID:
NCT05373433
Status:
UNKNOWN
Last Update Posted:
2022-05-24
First Post:
2022-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate SSD8432/Ritonavir in Adults With COVID-19
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-26
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-12
First Submit QC Date:
None
Study First Post Date:
2022-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-17
Last Update Post Date:
2022-05-24
Last Update Post Date Type:
ACTUAL